Efficacy of Interleukin-1 Targeting Treatments in Patients with Familial Mediterranean Fever

Inflammation

Volumn 38, Issue 1, 2015, Pages 27-31

  Cetin, Pinar ^a   Sari, Ismail ^a   Sozeri, Betul ^b   Cam, Ozlem ^b   Birlik, Merih ^a   Akkoc, Nurullah ^a   Onen, Fatos ^a   Akar, Servet ^c  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

^b EGE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^c IZMIR KATIP CELEBI UNIVERSITY   (Turkey)

Author keywords

amyloidosis; anakinra; canakinumab; colchicine; familial Mediterranean fever; interleukin 1 receptor antagonist protein; rilonacept

Indexed keywords

CANAKINUMAB; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; ANTAGONISTS AND INHIBITORS; DRUG DELIVERY SYSTEM; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; DRUG DELIVERY SYSTEMS; FAMILIAL MEDITERRANEAN FEVER; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84931282691     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-014-0004-1     Document Type: Article

References (15)

1. Sari, I., M. Birlik, and T. Kasifoglu. 2014. Familial Mediterranean fever: An updated review. European Journal of Rheumatology 1(1): 21–33.
2. Kasifoglu, T., S.Y. Bilge, I. Sari, D. Solmaz, S. Senel, H. Emmungil, L. Kilic, S.Y. Oner, F. Yildiz, S. Yilmaz, et al. 2014. Amyloidosis and its related factors in Turkish patients with familial Mediterranean fever: A multicentre study. Rheumatology (Oxford) 53(4): 741–745.
3. Mankan, A.K., A. Kubarenko, and V. Hornung. 2012. Immunology in clinic review series; focus on autoinflammatory diseases: Inflammasomes: Mechanisms of activation. Clinical and Experimental Immunology 167(3): 369–381.
4. Ozkurede, V.U., and L. Franchi. 2012. Immunology in clinic review series; focus on autoinflammatory diseases: Role of inflammasomes in autoinflammatory syndromes. Clinical and Experimental Immunology 167(3): 382–390.
5. Ben-Chetrit, E., and H. Ozdogan. 2008. Non-response to colchicine in FMF–definition, causes and suggested solutions. Clinical and Experimental Rheumatology 26(4 Suppl 50): S49–S51.
6. Hashkes, P.J., S.J. Spalding, E.H. Giannini, B. Huang, A. Johnson, G. Park, K.S. Barron, M.H. Weisman, N. Pashinian, A.O. Reiff, et al. 2012. Rilonacept for colchicine-resistant or -intolerant familial Mediterranean fever: A randomized trial. Annals of Internal Medicine 157(8): 533–541.
7. Meinzer, U., P. Quartier, J.F. Alexandra, V. Hentgen, F. Retornaz, and I. Kone-Paut. 2011. Interleukin-1 targeting drugs in familial Mediterranean fever: A case series and a review of the literature. Seminars in Arthritis and Rheumatism 41(2): 265–271.
8. Ozen, S., Y. Bilginer, N. Aktay Ayaz, and M. Calguneri. 2011. Anti-interleukin 1 treatment for patients with familial Mediterranean fever resistant to colchicine. Journal of Rheumatology 38(3): 516–518.
9. Stankovic Stojanovic, K., Y. Delmas, P.U. Torres, J. Peltier, G. Pelle, I. Jeru, M. Colombat, and G. Grateau. 2012. Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure. Nephrology, Dialysis, Transplantation 27(5): 1898–1901.
10. Akgul, O., E. Kilic, G. Kilic, and S. Ozgocmen. 2013. Efficacy and safety of biologic treatments in familial Mediterranean fever. American Journal of the Medical Sciences 346(2): 137–141.
11. Grattagliano, I., L. Bonfrate, V. Ruggiero, G. Scaccianoce, G. Palasciano, and P. Portincasa. 2014. Novel therapeutics for the treatment of familial Mediterranean fever: From colchicine to biologics. Clinical Pharmacology and Therapeutics 95(1): 89–97.
12. Livneh, A., P. Langevitz, D. Zemer, N. Zaks, S. Kees, T. Lidar, A. Migdal, S. Padeh, and M. Pras. 1997. Criteria for the diagnosis of familial Mediterranean fever. Arthritis and Rheumatism 40(10): 1879–1885.
13. Pras, M. 1998. Familial Mediterranean fever: From the clinical syndrome to the cloning of the pyrin gene. Scandinavian Journal of Rheumatology 27(2): 92–97.
14. Dinarello, C.A., S.M. Wolff, S.E. Goldfinger, D.C. Dale, and D.W. Alling. 1974. Colchicine therapy for familial Mediterranean fever. A double-blind trial. New England Journal of Medicine 291(18): 934–937.
15. Zemer, D., M. Revach, M. Pras, B. Modan, S. Schor, E. Sohar, and J. Gafni. 1974. A controlled trial of colchicine in preventing attacks of familial Mediterranean fever. New England Journal of Medicine 291(18): 932–934.